In the house I handed my oldest boy the broom and said, as I grabbed some more shells, “Hit me over the head. I just missed ...

Explore Harding Loevner's Q3 2025 Global Small Companies report. Learn why momentum markets impacted returns and our ...

Q3 2025 Earnings Call Transcript November 6, 2025 EPAM Systems, Inc. misses on earnings expectations. Reported EPS is $1.89 ...

Starring Russell Crowe as the high-ranking Nazi and Rami Malek as Army officer Douglas M. Kelley, the film dramatizes the ...

Infineon Technologies AG ( OTCQX:IFNNY) Q4 2025 Press Conference Call November 12, 2025 2:00 AM EST ...

This quarter introduced new opportunities while reinforcing the broadening appeal of some of our mainstay technologies,” said P. Peter Pascali, President and CEO of PyroGenesis Inc. “The $1.2 million ...

Artiva remains on track to share initial clinical response data and conduct U.S. Food and Drug Administration (FDA) regulatory interactions to align on pivotal trial design for AlloNK in refractory ...

US President Donald Trump on Sunday suggested giving most Americans a $2,000 payment funded through tariff revenues collected ...

AlloNK plus anti-CD20 monoclonal antibody (mAb) as of October 1, 2025, data cutoff All patients received AlloNK as outpatients, and the majority were ...

The UK Parliament has introduced a new Cyber Security and Resilience Bill to strengthen the defenses of critical sectors, ...

Nocs has aimed this scope for the mass market, with a low price point and we were impressed with its overall performance.

Recombinant human fibroblast growth factors offer growth prospects in regenerative medicine and cosmetics, driven by efficient production systems. Key opportunities arise from applications in wound ...